Aragen offers a comprehensive range of solutions to develop and supply formulations for toxicology studies. Our expertise encompasses conventional formulations (suspension, solutions) and novel formulation technologies (microemulsion, nanosuspension, solid dispersion) to enhance bioavailability and modified release technologies (liposomes, microparticles) for parenteral delivery, as well as topical formulations.
We have multidisciplinary teams with experience in formulation development and establishing IVIVC in preclinical species. Our developability assessment leads to accurate identification of clinical development strategies, saving significant time at this stage. Strong project management and collaboration between discovery teams enable rapid and seamless progress of molecules, leading to successful IND filings.
Toxicology Formulation
All preclinical species
Conventional formulations
Enabling formulations to enhance in vivo exposure
Formulation supplies for all routes of administration
Micronization, spray drying and nanosuspension supplies
Reliable and reproducible analytical data to support speedy filing for regulatory approval.
FAQ
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit
